Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma

Fig. 1

Synthesis and characterization of PH1. a Synthesis of PEG3350-PEI600-CyD. b H1NMR analysis of PEG3350, PEI600-CyD, and PEG3350-PEI600-CyD. c Particle size of PH1/plasmid polyplexes at the N/P ratio of 20/1. d Zeta potential of PH1/plasmid polyplexes at the N/P ratio of 20/1. e In vitro transfection effciency assay of PH1 in 293 T cells. f Distribution analysis of YOYO-1 labeled pHGFK1 was performed with in vivo optical imaging system

Back to article page